Valuation: InterCure Ltd.

Market Cap 200M 0 178M 166M 151M 285M 19.26B 289M 2.01B 778M 9.81B 751M 735M 31.51B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 336M 0 299M 279M 255M 479M 32.39B 486M 3.38B 1.31B 16.5B 1.26B 1.24B 52.98B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.82%
Yield 2024 *
-
Yield 2025 -
1 day+0.72%
1 week+0.66%
Current month+0.72%
1 month-1.40%
3 months-0.32%
6 months+42.23%
Current year+4.39%
1 week 1,584
Extreme 1584
1,700
1 month 1,569
Extreme 1569
1,702
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,783.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 67 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Other

Chief Financial Officer

539,947 0.9874%
3/18/26 Other

Director

19,046 0.0348%
3/18/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%+0.66%-38.46%-45.48% 64.76M
-0.57%+0.18%+10.84%+22.03% 110B
-0.79%-0.02%-0.63%+72.12% 92.39B
-1.17%-0.08%+152.75%+823.10% 59.58B
-4.87%-3.36%-6.75%+50.03% 28.62B
-0.85%-2.32%+26.92%+89.64% 25.72B
-1.14%-1.41%+9.15%+51.50% 24.99B
-0.57%+0.09%-15.97%-6.32% 21.11B
-0.62%+1.78%+26.14%+285.45% 20.58B
+0.39%-3.74%-6.42%+33.74% 16.95B
Average -0.95%-0.90%+15.76%+137.58% 39.96B
Weighted average by Cap. -1.03%-0.54%+27.65%+173.79%

Financials

2024 2025
Net sales 239M 0 212M 198M 181M 340M 23B 345M 2.4B 929M 11.71B 897M 877M 37.62B 270M 0 240M 224M 205M 385M 26.02B 390M 2.72B 1.05B 13.25B 1.01B 992M 42.55B
Net income -67.8M -0 -60.22M -56.31M -51.32M -96.61M -6.53B -97.94M -681M -264M -3.32B -255M -249M -10.68B -35.71M -0 -31.72M -29.66M -27.03M -50.89M -3.44B -51.59M -359M -139M -1.75B -134M -131M -5.62B
Net Debt 133M 0 118M 110M 100M 189M 12.78B 192M 1.33B 516M 6.51B 498M 488M 20.91B 136M 0 121M 113M 103M 194M 13.13B 197M 1.37B 530M 6.69B 512M 501M 21.47B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-10-01 ILA 1,689.00 +0.72% 608
26-09-30 ILA 1,677.00 +2.26% 3,385
26-09-29 ILA 1,640.00 +1.93% 2,113
26-09-28 ILA 1,609.00 -4.11% 4,975
26-09-24 ILA 1,678.00 -0.12% 3,541
  1. Stock Market
  2. Stocks
  3. INCR Stock